Aramark Earnings Call Highlights Strong Underlying Momentum

ARAMARK Holdings Corp. ((ARMK)) has held its Q1 earnings call. Read on for the main highlights of the call.

Valentine's Day Sale - 70% Off

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Aramark’s latest earnings call carried a distinctly upbeat tone, with management stressing strong underlying growth despite some technical headwinds. Executives emphasized record client retention, major new contract wins, and particularly strong international performance, while downplaying the impact of a calendar quirk and seasonal cash usage on short‑term results.

Broad-Based Organic Revenue Growth

Aramark reported 5% organic revenue growth in Q1 to $4.8 billion, but management argued this understated momentum. A 53rd‑week calendar shift reduced reported revenue by about $125 million, implying underlying organic growth closer to 8% once timing effects are stripped out.

FSS US Shows Underlying Strength

Food and Support Services U.S. delivered 2% organic revenue growth to $3.4 billion, with management pointing to a roughly 5% increase when adjusted for the calendar shift. Workplace experience, refreshments, healthcare, sports and entertainment, and corrections were all cited as key contributors to this underlying momentum.

International Business Continues to Outperform

International organic revenue exceeded $1.5 billion, rising more than 13% year over year and extending a 19‑quarter streak of double‑digit growth. All countries contributed, with standout performances from the U.K., Spain, Germany, and Chile, supported by more than 100 core account wins during the quarter.

Profitability Holds Up Despite Timing Drag

Operating income came in at $218 million, slightly higher than a year ago, while adjusted operating income reached $263 million, up 1% in constant currency. Management highlighted that AOI would have grown about 11% if not for the estimated $25 million negative impact from the calendar shift.

Flagship Wins in Healthcare and Corrections

The company announced several marquee contract wins that should fuel future growth, including Penn Medicine, described as its largest U.S. contract ever, and RWJBarnabas Health, covering 18 locations and 5,700 beds. Aramark also secured a statewide Alabama corrections deal spanning 27 facilities, plus significant mining wins such as Chilean giant Codelco.

Record Client Retention Bolsters Revenue Base

Management underscored that client retention is at unprecedented levels for this point in the fiscal year, characterizing it as virtually flawless. This strong retention profile supports net‑new growth and adds visibility to recurring revenue, reducing churn risk as new contracts ramp.

Supply Chain Scale and AI Drive Efficiency

Aramark’s global supply chain and GPO operations posted double‑digit growth and now support more than $20 billion of contracted spend. The company is increasingly deploying AI tools, including mobile chatbots and analytics systems, to enhance procurement insights, streamline back‑office work, and unlock productivity gains.

Capital Allocation and Balance Sheet Moves

The company repurchased $30 million of shares and improved its capital structure by repricing $2.4 billion of 2030 term loans, trimming interest costs by roughly 25 basis points. Quarter‑end cash availability stood at about $1.4 billion, giving Aramark flexibility to fund growth and shareholder returns.

Calendar Shift Distorts Quarterly Optics

A 53rd week in fiscal 2025 is reshaping the timing of reported results, with Q1 revenue reduced by roughly 3% and AOI by about $25 million. Management said this timing effect also reduced adjusted EPS growth by around 13% in Q1 and stressed that while quarterly cadence will look uneven, the full‑year economics are unchanged.

Seasonal Cash and Working Capital Pressures

The company experienced a normal seasonal cash outflow in Q1, but it was roughly $200 million higher than last year. Management attributed the increase to heavier working capital needs tied to strong growth and the timing of large new account rollouts, implying these pressures are more a function of expansion than weakness.

Elevated CapEx Reflects Growth Investments

Capital expenditures reached about 4.5% of revenue in Q1, above the historical norm of roughly 3.5%, largely due to investments required to onboard sizable new contracts. Executives expect CapEx intensity to ease and normalize by year‑end as these mobilizations move from build‑out to steady‑state operations.

U.S. AOI Dip Masked Underlying Growth

Adjusted operating income in the U.S. slipped about 1% year over year in Q1, but management framed this as a timing issue driven by the calendar shift. They estimate that without the shift, U.S. AOI would have increased around 9%, suggesting the domestic profitability trend is stronger than the headline figure implies.

Start-Up Costs Temper International Margins

International AOI still grew roughly 12% in constant currency, but margins were partially pressured by mobilization and start‑up costs on new contracts. These were concentrated in Sports and Entertainment and Higher Education deals, and management presented them as temporary costs that set up multi‑year revenue streams.

Managing Inflation and Commodity Pressures

Inflation ran close to management’s expectations in Q1, with pricing averaging about 3% to offset higher costs. Certain commodities, particularly beef, remain elevated and present upside risk, but Aramark believes a mix of pricing actions and operational levers will absorb most of the impact.

Event Timing Weighs on Q1 Comparisons

Revenue in the quarter also faced a small headwind from about nine fewer MLB games compared with the prior year. Management expects this event‑driven cadence to normalize in Q2, which should help support sports and entertainment volumes as the year progresses.

Guidance and Outlook Remain Firmly Positive

Aramark reiterated its fiscal 2026 targets, calling for 7%–9% organic revenue growth, 12%–17% AOI growth, and a 20%–25% increase in adjusted EPS while reducing leverage below 3x. Management noted Q2 should see an opposite roughly 3% revenue benefit from the calendar shift and expressed high confidence that strong pipelines, international momentum, and supply chain scale will support these goals.

Aramark’s earnings call painted a picture of a company gaining ground beneath some noisy quarterly optics. With robust international growth, record retention, major strategic wins, and disciplined capital moves, management argued that timing and seasonal pressures are temporary, while the structural trends behind its long‑term growth and margin expansion story remain intact.

Disclaimer & DisclosureReport an Issue